Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Wellcome Centre for Human Genetics researcher Dr Ross Chapman has been selected has one European Molecular Biology Laboratory's Young Investigators for 2018.

The EMBO Young Investigator Programme identifies recent group leaders with a proven record of scientific excellence and offers them access to a range of benefits during their four-year tenure. These include an award of 15,000 euros, with the potential for additional funding, mentorship by a senior scientist from the community of EMBO Members, access to training in leadership skills and responsible research practices, as well as networking opportunities.

Read the full article

Similar stories

New vaccine trial for Middle East Respiratory Syndrome launched

A new clinical trial to find a vaccine to protect people against Middle East Respiratory Syndrome (MERS) launched on 15 September 2023. This is the third Phase I clinical trial of the ChAdOx1 MERS vaccine, developed by researchers at the Pandemic Sciences Institute. It is the first trial in older people.